Søren T Hoff Selected Research

IC31 adjuvant

1/2017

H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Søren T Hoff Research Topics

Disease

10	Tuberculosis (Tuberculoses) 01/2018 - 06/2010
4	Infections 06/2017 - 07/2007
1	Persistent Infection 06/2017
1	Latent Infection 01/2017
1	Fever (Fevers) 01/2017
1	Pain (Aches) 01/2017
1	Arthralgia (Joint Pain) 01/2017
1	Myalgia 01/2017
1	Pulmonary Tuberculosis 03/2011

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 06/2017 - 03/2011
3	AntigensIBA 06/2017 - 01/2017
3	Tuberculin (PPD)IBA 01/2017 - 06/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
1	Subunit VaccinesIBA 01/2018
1	IC31 adjuvantIBA 01/2017
1	InterferonsIBA 01/2017
1	Protein Subunits (Protein Subunit)IBA 01/2017
1	Liposomes (Liposome)IBA 12/2014
1	BCG Vaccine FDA Link 03/2011
1	Indicators and Reagents (Reagents)IBA 06/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007
1	Interleukin-2 (IL2)IBA 07/2007
1	Interferon-gamma (Interferon, gamma)IBA 07/2007

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2016